Similar articles

• [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].

  Manabe A. Manabe A. Rinsho Ketsueki. 2012 Aug;53(8):729-33. Rinsho Ketsueki. 2012. PMID: 22975811 Review. Japanese. No abstract available.
• Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay.

  Tanaka M, Takahashi Y, Xu Y, Yoshida N, Yoshimi A, Villalobos IB, Hama A, Nishio N, Hidaka H, Wang Y, Yagasaki H, Kojima S. Tanaka M, et al. Leuk Res. 2008 Jul;32(7):1036-42. doi: 10.1016/j.leukres.2007.11.016. Epub 2008 Mar 4. Leuk Res. 2008. PMID: 18164384
• Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.

  Sugimoto Y, Muramatsu H, Makishima H, Prince C, Jankowska AM, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP. Sugimoto Y, et al. Br J Haematol. 2010 Jul;150(1):83-7. doi: 10.1111/j.1365-2141.2010.08196.x. Epub 2010 Apr 12. Br J Haematol. 2010. PMID: 20408841
• Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.

  De Filippi P, Zecca M, Lisini D, Rosti V, Cagioni C, Carlo-Stella C, Radi O, Veggiotti P, Mastronuzzi A, Acquaviva A, D'Ambrosio A, Locatelli F, Danesino C. De Filippi P, et al. Br J Haematol. 2009 Dec;147(5):706-9. doi: 10.1111/j.1365-2141.2009.07894.x. Epub 2009 Sep 22. Br J Haematol. 2009. PMID: 19775298
• [Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].

  Koike K, Matsuda K. Koike K, et al. Rinsho Ketsueki. 2013 Jun;54(6):538-44. Rinsho Ketsueki. 2013. PMID: 23823092 Review. Japanese. No abstract available.